PEBP1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-PEBP1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPEBP1
Clone[AT4B11]
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG2b, k
FormatProtein A purified
Size0.05 mL, 0.1 mL
Concentration1 mg/ml
ApplicationsELISA (EIA), Western Blot (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionPhosphatidylethanolamine binding protein 1 (PEBP1), also known as Raf kinase inhibitor protein (RKIP), is a member of the phosphatidylethanolamine-binding protein family and a serine protease inhibitor which inhibits thrombin, neuropsin. PEBP1 plays a pivotal modulatory role in several protein kinase signaling cascades. Protein kinase C (PKC) phosphorylates PEBP1, resulting in release of Raf-1 and activation of MEK and ERK. Expressed in many tissues, PEBP1 is implicated in the regulation of such physiological processes as membrane biosynthesis, spermatogenesis, neural development, and metastasis suppression.
ImmunogenImmunogen: Recombinant human PEBP1 (1-187aa) purified from E. coli
Other Names[Phosphatidylethanolamine-binding protein 1; HCNP; Pbp; Pbp1; Pbqr; Rkip], [PEBP1; PEBP1; PBP; HCNP; PEBP; RKIP; HCNPpp; PEBP-1; HEL-210; HEL-S-34; HEL-S-96; PBP; PEBP; PEBP-1; RKIP; HCNP]
Gene, Accession #[PEBP1], Gene ID: 5037, NCBI: NP_002558, UniProt: P30086
Catalog #MBS200462
Price$240, $315
Order / More InfoPEBP1 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesKeller ET., et al. (2004) Biochem Pharmacol. 68 (6): 1049-53. ; Park S., et al. (2005) Oncogene. 24 (21): 3535-40.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.